CML – is difficult to monitor and manage using traditional solutions. New RNA-based assays are hitting the market to make ...

Basel, October 29, 2024 – Novartis announced today that Scemblix ® (asciminib) was granted accelerated approval by the US Food and Drug Administration (FDA) for adult patients with newly diagnosed ...

Single-cell analysis of CML patients bone marrow at diagnosis reveals coexistence of CD26-CD35+ healthy stem cells and CD26+CD35- CML stem cells, and how the ratio between these impacts TKI response.

The opioid addiction treatment market will be worth $2.4bn by 2033, driven by diagnoses in the eight major world markets.

OKYO Pharma has initiated the Phase II trial of OK-101, a treatment for neuropathic corneal pain (NCP), by dosing the first ...

Its kit for chronic myeloid leukemia (CML) will begin the regulatory approval process with ... Launched by the company in 2021, the LQ Suite Digital PCR platform, based on microdroplet technology, ...

and chronic myeloid leukemia (CML). This innovative technology offers significant advantages over traditional diagnostic methods, especially in resource-limited settings. By providing timely and ...

The global leukemia therapeutics treatment market has seen considerable growth, progressing from USD 14,504.8 million in 2022 to USD 15,246.7 million in 2023. With a projected compound annual growth ...

This innovative tokenization initiative aims to revolutionize the mining sector by providing a new financing model for mining operations by leveraging the assets. Cunningham Mining Ltd (“CML”) has ...

Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today ...

Join the CML Book Club! The CTV Morning Live hosts will share a new title each month. Read along, share your thoughts, and recommend your favourite books. The CML Book Club’s first selection is ...

Based on RNA technology, ICON’s new assay offers huge improvements on how CML is monitored ... NGS assay known as Dup-Seq BCR::ABL1. This innovative assay enables the identification of both ...